Transcriptional profiles of Trichophyton rubrum in response to itraconazole

References

• Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995; 8: 240–259
   PubMed Web of Science ®Google Scholar
• Gong JQ, Liu XQ, Xu HB, et al. Deep dermatophytosis caused by Trichophyton rubrum: report of two cases. Mycoses 2007; 50: 102–108
   PubMed Web of Science ®Google Scholar
• Tsang P, Hopkins T, Jimenez-Lucho V. Deep dermatophytosis caused by Trichophyton rubrum in a patient with AIDS. J Am Acad Dermatol 1996; 34: 1090–1091
   PubMed Web of Science ®Google Scholar
• Lestringant GG, Lindley SK, Hillsdon-Smith J, et al. Deep dermatophytosis to Trichophyton rubrum and T. verrucosum in an immunosuppressed patient. Int J Dermatol 1986; 27: 707–709
   Google Scholar
• Marques SA, Robles AM, Tortorano AM, et al. Mycoses associated with AIDS in the Third World. Med Mycol 2000; 38: 269–279
   PubMed Web of Science ®Google Scholar
• Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol 1996; 35: 539–542
   PubMed Web of Science ®Google Scholar
• Del Palacio, A, Garau, M, Gonzalez-Escalada, A, . Trends in the treatment of dermatophytosis. In:. RKS Kushwaha, et al, Guarro, J, Biology of Dermatophytes and Other Keratinophilic Fungi. Bilbao, País VascoSpain:Revista Iberoamericana de Micología. 2000:148–158.
   Google Scholar
• Hay RJ, Clayton YM, Moore MK, et al. Itraconazole in the management of chronic dermatophytoses. J Am Acad Dermatol 1990; 23: 561–564
   PubMed Web of Science ®Google Scholar
• Nagino K, Shimohira H, Ogawa M, et al. Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis. J Infect Chemother 2000; 6: 41–44
   PubMedGoogle Scholar
• Roberts DT. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails. Dermatology 1997; 194: 37–39
   PubMedGoogle Scholar
• Saul A, Bonifaz A, Arias I. Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Rev Infect Dis 1987; 9: S100–S103
   Google Scholar
• Lupetti A, Danesi R, Campa M, et al. Molecular basis of resistance to azole antifungals. Trends Mol Med 2002; 8: 76–81
   PubMed Web of Science ®Google Scholar
• Agarwal AK, Rogers PD, Baerson SR, et al. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J Biol Chem 2003; 278: 34998–5015
   PubMed Web of Science ®Google Scholar
• Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nature Genetics 1999; 21: 33–37
   PubMed Web of Science ®Google Scholar
• Bammert GF, Fostel JM. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob Agents Chemother 2000; 44: 1255–1265
   PubMed Web of Science ®Google Scholar
• Liu TT, Lee REB, Barker KS, et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 2005; 49: 2226–2236
   PubMed Web of Science ®Google Scholar
• GS De Hoog, Guarro, J, Gené, J. Atlas of Clinical Fungi, 2nd edn. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands, and University Rovirai Virgili, Reus, Spain. 2000.
   Google Scholar
• DH Larone. Medically Important Fungi: A Guide to Identification, 4th edn. Washington, DC:American Society for Microbiology, 2002.
   Google Scholar
• Jackson CJ, Barton RC, Evans EGV. Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal-DNA intergenic spacer regions. J Clin Microbiol 1999; 37: 93–936
   Google Scholar
• Meevootisom V, Niederpruem DJ. Control of exocellular proteases in dermatophytes and especially Trichophyton rubrum. Sabouraudia 1979; 17: 91–106
   PubMedGoogle Scholar
• Wang L, Ma L, Leng W, et al. Analysis of the dermatophyte Trichophyton rubrum expressed sequence tags. BMC Genomics 2006; 7: 255
   Google Scholar
• Peng J, Zhang X, Yang J, et al. The use of comparative genomic hybridization to characterize genome dynamics and diversity among the serotypes of Shigella. BMC Genomics 2006; 7: 218
   PubMed Web of Science ®Google Scholar
• Diehl F, Grahlmann S, Beier M, et al. Manufacturing DNA-microarrays of high spot homogeneity and reduced background signal. Nucl Acids Res 2001; 29: E38
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA, 2002.
   Google Scholar
• Fernandez-Torres B, Cabanes FJ, Carrillo-Munoz AJ, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999–4003
   PubMed Web of Science ®Google Scholar
• Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979; 74: 829–836
   Web of Science ®Google Scholar
• Saeed AI, Sharov V, White J, et al. TM4: a free, open- source system for microarray data management and analysis. Biotechniques 2003; 34: 374–378
   PubMed Web of Science ®Google Scholar
• Barry AL, Pfaller MA, Brown SD, et al. Quality control limits of broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol 2000; 38: 3457–3459
   PubMed Web of Science ®Google Scholar
• Yang J, Chen L, Wang L, et al. TrED: the Trichophyton rubrum expression database. BMC Genomics 2007; 8: 250
   Google Scholar
• Ghannoum MA, Rice LB. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12: 501–517
   PubMed Web of Science ®Google Scholar
• Liu TT, Lee RE, Barker KS, et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 2005; 49: 2226–2236
   PubMed Web of Science ®Google Scholar
• White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382–402
   PubMed Web of Science ®Google Scholar
• White TC. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases on azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 1997; 42: 1488–1494
   Google Scholar
• Swain E, Baudry K, Stukey J, et al. Sterol-dependent regulation of sphingolipid metabolism in Saccharomyces cerevisiae. J Biol Chem 2002; 277: 26177–26184
   Google Scholar
• Majumder AL, Johnson MD, Henry SA. 1L-myo-inositol-1-phosphate synthase. Biochem Biophys Acta 1997; 1348: 245–256
   PubMedGoogle Scholar
• Arganoff BW, Fisher SK. Phosphoinositides and their stimulated breakdown. Inositol Phosphates and Derivatives, AB Reitz. American Chemical Society, Washington, DC 1991; 20–32
   Google Scholar
• Exton JH. Mechanisms involved in calcium-mobilizing agonist responses. Adv Cyclic Nucl Prot Phosphor Res 1986; 20: 211–262
   Google Scholar
• Potter BVL, Lampe D. Chemistry of inositol lipid mediated cellular signaling. Angew Chem Int Ed Engl 1995; 34: 1933–1972
   Web of Science ®Google Scholar
• Mao C, Obeid LM. Yeast sphingosine-1-phosphate phosphatases: assay, expression, deletion, purification and cellular localization by GFP tagging. Meth Enzymol 2000; 311: 223–232
   PubMedGoogle Scholar
• De Backer MD, Ilyina T, Ma X, et al. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother 2001; 45: 1660–1670
   PubMed Web of Science ®Google Scholar
• Hwang CS, Rhie GE, Oh JH, et al. Copper- and zinc-containing superoxide dismutase (Cu/ZnSOD) is required for the protection of Candida albicans against oxidative stresses and the expression of its full virulence. Microbiology 2002; 148: 3705–3713
   PubMed Web of Science ®Google Scholar
• Culotta VC, Joh HD, Lin SJ, et al. A physiological role for Saccharomyces cerevisiae copper/zinc superoxide dismutase in copper buffering. J Biol Chem 1995; 270: 29991–29997
   PubMed Web of Science ®Google Scholar
• Hwang CS, Baek YU, Yim HS, et al. Protective roles of mitochondrial manganese-containing superoxide dismutase against various stresses in Candida albicans. Yeast 2003; 20: 929–941
   Google Scholar
• Veal EA, Toone WM, Jones N, et al. Distinct roles for glutathione S-transferases in the oxidative stress response in Schizosaccharomyces pombe. J Biol Chem 2002; 277: 35523–35531
   PubMed Web of Science ®Google Scholar
• Rogers PD, Barker KS. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicr Agents Chemother 2003; 47: 1220–1227
   PubMed Web of Science ®Google Scholar
• White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382–402
   PubMed Web of Science ®Google Scholar
• Jung US, Levin DE. Genome-wide analysis of gene expression regulated by the yeast cell wall integrity-signalling pathway. Mol Microbiol 1999; 34: 1049–1057
   PubMed Web of Science ®Google Scholar
• Rogers B, Decottignies A, Kolaczkowski M, et al. The pleitropic drug ABC transporters from Saccharomyce scerevisiae. J Mol Microbiol Biotechnol 2001; 3: 207–14
   PubMed Web of Science ®Google Scholar
• Balzi E, Goffeau A. Yeast multidrug resistance: the PDR network. J Bioenerg Biomembr 1995; 27: 71–76
   PubMed Web of Science ®Google Scholar
• Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part II. J Am Acad Dermatol 1994; 30: 911–933
   PubMed Web of Science ®Google Scholar
• Edlind T, Smith L, Henry K, et al. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signaling. Mol Microbiol 2002; 46: 257–268
   PubMed Web of Science ®Google Scholar